BHF-04REV B.1BHF

Crosslinked Hyaluronan Hydrogel ECM

Thiol-ene crosslinked methacrylated hyaluronic acid hydrogel with storage modulus G′ ≈ 1.2 kPa, controlled enzymatic degradation, and tunable RGD presentation.

Engineering DescriptionBHF-04 · DESC

The primary extracellular matrix mimic is a methacrylated hyaluronic acid (MeHA) hydrogel crosslinked through visible-light thiol-ene chemistry with a 4-arm PEG-dithiol (lithium phenyl-2,4,6-trimethylbenzoylphosphinate photoinitiator, 405 nm, 5 mW/cm², 60 s). This avoids the cytotoxicity of UV/Irgacure 2959 systems while preserving cell viability >95 % at encapsulation.

Bulk mechanical tuning targets G′ of 1.2 kPa (soft dermal tissue) and a loss tangent below 0.10 at 1 Hz. RGD adhesion peptide is conjugated at 1.5 mM via thiol-Michael addition for integrin engagement. Hyaluronidase-mediated degradation half-life is held at ≈ 14 days in vitro to coincide with the scaffold ingrowth window.

Technical ParametersBHF-04 · TABLE
ParameterValueUnitTolerance / Note
Base polymerMethacrylated HAMethacrylation DS ≈ 25 %
Crosslinker4-arm PEG-dithiol
PhotoinitiatorLAP 0.05 % w/v
Cure405 nm / 5 mW/cm² / 60 s
Storage modulus G′1.2kPa1 Hz, 37 °C
Loss tangent (tan δ)<0.101 Hz
RGD density1.5mM
Degradation t½~14daysHyaluronidase mediated
Cell viability post-cure>95%